Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC: Clinical scenarios affecting survival

Kroeze, S G C; Fritz, C; Kaul, D; Blanck, O; Kahl, K; Roeder, F; Siva, S; Verhoeff, J J C; Grosu, A L; Schymalla, M M; Glatzer, M; Szuecs, M; Geier, M; Skazikis, G; Sackerer, I; Lohaus, F; Eckert, F; Guckenberger, M

doi:https://doi.org/10.1093/annonc/mdz063.071

Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC: Clinical scenarios affecting survival

DSpace/Manakin Repository

Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC: Clinical scenarios affecting survival

Kroeze, S G C; Fritz, C; Kaul, D; Blanck, O; Kahl, K; Roeder, F; Siva, S; Verhoeff, J J C; Grosu, A L; Schymalla, M M; Glatzer, M; Szuecs, M; Geier, M; Skazikis, G; Sackerer, I; Lohaus, F; Eckert, F; Guckenberger, M

(2019) Annals of oncology : official journal of the European Society for Medical Oncology, volume 30, issue Supplement 2, pp.

(Article)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Hematology, Oncology

DOI: https://doi.org/10.1093/annonc/mdz063.071

ISSN: 0923-7534

Publisher: Oxford University Press

(Non peer reviewed)